Five-year recurrence-free rates of 89.4% and 83.9% indicate durable disease control after ProSense cryoablation in localized ...
Top-line findings from the ICESECRET clinical trial (NCT02399124) featuring the ProSense Cryoablation System for the ...
IceCure Medical Ltd. announced positive top-line results from its ICESECRET clinical trial of its ProSense cryoablation ...
IceCure Medical Ltd. (NASDAQ:ICCM), the developer of minimally invasive cryoablation technology that destroys tumors by freezing them, was granted marketing authorization from the U.S. Food and Drug ...
BERKELEY, Calif.--(BUSINESS WIRE)--Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced that the first ...
Lucia Gaitan, M.D., FACOG, Lucia Gaitan, M.D., FACOG MIAMI, March 19, 2026 (GLOBE NEWSWIRE) -- In a release issued under the ...
Can harnessing ice-cold temperatures result in healthier locks? The experts weigh in ...
Cryo-focused ion beam (cryo-FIB) milling is indispensable for preparing thin lamellae from thick biological samples for cryo-electron tomography (cryo-ET), especially at the tissue level. However, ...
BERKELEY, Calif.--(BUSINESS WIRE)--Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced that the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results